N/A
Completed N=53,132
Physician Coaching to Reduce Opioid-related Harms
Substance Abuse · Postoperative Pain
Source: ClinicalTrials.gov NCT02433496 ↗
Enrolled (actual)
53,132
Serious AEs
0.0%
Results posted
Jul 2018
Primary outcomePrimary: Overall Rate of Opioid Prescribing — 0.012; 0.013 Proportion of patients
Summary
This project pilot tests an innovative clinical guideline translation and physician coaching model to promote adherence to evidence-based guidelines for the prescribing of opioid pain medications in primary care settings.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Overall Rate of Opioid Prescribing |
0.012; 0.013 | — |
| SECONDARY Rate of Opioid / Benzodiazepine Co-prescribing |
0.074; 0.061 | — |
| SECONDARY Urine Drug Screening Rate |
0.645; 0.440 | — |
| SECONDARY Mental Health Screening Rate |
0.574; 0.394 | — |
| SECONDARY Use of Pain Management Agreements |
0.782; 0.542 | — |
| SECONDARY High-dose Patients |
0.191; 0.125 | — |
| SECONDARY Provider Drop-out Rate |
0; 0 | — |
| SECONDARY Participating Patient Demographics |
47.1; 49.7; 2.2; 2.5; 2.4; 1.6 | — |
| SECONDARY Participating Clinic Characteristics |
29956; 13296; 9813; 34; 13; 20 | — |
| SECONDARY Participating Staff Characteristics |
6; 1; 4; 3; 1; 2 | — |
| SECONDARY Intervention Fidelity |
237.7; 85.7 | — |
| SECONDARY Intervention Cost |
29379 | — |
| SECONDARY Proportion With MEDD >120 mg |
0.191; 0.125 | — |
| SECONDARY Average Morphine Equivalent Daily Dose (MEDD) |
84.3; 60.2 | — |
Eligibility Criteria
Inclusion Criteria
At each of the 4 coaching intervention sites, we aim to recruit between 3-7 clinical care providers with prescribing authority (e.g., primary care physicians, mid-level practitioners, etc.) to participate in interviews and focus groups. All clinic staff (e.g., medical assistants, office staff) are welcome to participate in coaching site visits and follow up correspondence, but only staff with prescribing authority will be considered research participants.
Exclusion Criteria
- Residents will be excluded.
Data sourced from ClinicalTrials.gov (NCT02433496). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.